During the past decade, Hospital Evora conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Evora" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Baxter Healthcare Corporation" with 1 trials sponsored, "Biogen" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Fundación EPIC" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

According to Clinical.Site data, the most researched conditions in "Hospital Evora" are "Breast Cancer" (2 trials), "Atrial Fibrillation" (1 trials), "BRAF V600 Mutation" (1 trials), "Breast Tumor" (1 trials) and "Cancer of the Breast" (1 trials). Many other conditions were trialed in "Hospital Evora" in a lesser frequency.

Most popular intervention types in "Hospital Evora" are "Drug" (3 trials), "Device" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Gemcitabine" (1 trials), "Irradiation" (1 trials), "Pulmonary function Testing" (1 trials) and "XIENCE Sierra" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Evora" are 8 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Evora". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hospital Evora, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Evora, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".